dihydroxyphenylalanine has been researched along with Cardiomyopathies in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moussouttas, M | 1 |
| Lai, EW | 1 |
| Dombrowski, K | 1 |
| Huynh, TT | 1 |
| Khoury, J | 1 |
| Carmona, G | 1 |
| DeCaro, M | 1 |
| Pacak, K | 1 |
| Anichkov, SV | 1 |
| Zavodskaya, IS | 1 |
| Moreva, EV | 1 |
2 other studies available for dihydroxyphenylalanine and Cardiomyopathies
| Article | Year |
|---|---|
CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cardiomyopathies; Catecholamines; Dihydroxyphenylalanine; Dopa | 2011 |
Influence of catecholamines on development of myocardial neurodystrophies.
Topics: Animals; Autonomic Nervous System; Bretylium Compounds; Cardiomyopathies; Dihydroxyphenylalanine; El | 1971 |